Non-spherical micro- and nanoparticles: Fabrication, characterization and drug delivery applications

Expert Opinion on Drug Delivery

Volumn 12, Issue 3, 2015, Pages 481-492

  Mathaes, Roman ^a   Winter, Gerhard ^a   Besheer, Ahmed ^a   Engert, Julia ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Non spherical particles; Particle fabrication techniques; Particle shape; Shape analytics

Indexed keywords

NANOPARTICLE; DRUG; DRUG CARRIER; NANOMATERIAL;

CIRCULATION TIME; DRUG DELIVERY SYSTEM; FIELD FLOW FRACTIONATION; FILM; FLOW CYTOMETRY; HUMAN; IMAGING; MICROFLOW IMAGING; MICROFLUIDICS; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; REVIEW; SCANNING ELECTRON MICROSCOPY; CHEMISTRY; ELECTRON MICROSCOPY; MEDICINAL CHEMISTRY;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; FLOW CYTOMETRY; MICROSCOPY, ELECTRON; NANOPARTICLES; NANOSTRUCTURES; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS;

EID: 84923345543     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2015.963055     Document Type: Review

References (113)

1. Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60
2. Dave N, Liu J. Liposomes for DNA nanotechnology: preparation, properties, and applications. In: Fan C, editor. DNA nanotechnology. Springer; Berlin, Heidelberg: 2013. p. 57-76
3. Kirtane AR, Panyam J. Polymer nanoparticles: weighing up gene delivery. Nat Nanotechnol 2013;8:805-6
4. Getts DR, Martin AJ, McCarthy DP, et al. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol 2012;30:1217-24
5. Koyamatsu Y, Hirano T, Kakizawa Y, et al. pH-responsive release of proteins from biocompatible and biodegradable reverse polymer micelles. J Control Release 2014;173:89-95
6. Kato Y, Inoue A, Niidome Y, Nakashima N. Thermodynamics on soluble carbon nanotubes: how do DNA molecules replace surfactants on carbon nanotubes? Sci Rep 2012;2:733
7. Noble ML, Kuhr CS, Graves SS, et al. Ultrasound-Targeted microbubble destruction-mediated gene delivery into canine livers. Mol Ther 2013;21:1687-94
8. Smith DM, Simon JK, Baker Jr. JR. Applications of nanotechnology for immunology. Nat Rev Immunol 2013;13:592-605
9. Arima H, Arizono M, Higashi T, et al. Potential use of folate-polyethylene glycol (PEG)-Appended dendrimer (G3) conjugate with [alpha]-cyclodextrin as DNA carriers to tumor cells. Cancer Gene Ther 2012;19:358-66
10. Zagorovsky K, Chan WC. Bioimaging: illuminating the deep. Nat Mater 2013;12:285-7
11. Cassidy MC, Chan HR, Ross BD, et al. In vivo magnetic resonance imaging of hyperpolarized silicon particles. Nat Nanotechnol 2013;8:363-8
12. Wang J, Zhang G, Li Q, et al. In vivo self-bio-imaging of tumors through in situ biosynthesized fluorescent gold nanoclusters. Sci Rep 2013;3:1157
13. Clyne M. Prostate cancer: magnetic particle thermotherapy for treating bone metastases. Nat Rev Urol 2013;10:125-5
14. Irvine DJ, Swartz MA, Szeto GL. Engineering synthetic vaccines using cues from natural immunity. Nat Mater 2013;12:978-90
15. Willyard C. First vaccines targeting cruise ship virus sail into clinical trials. Nat Med 2013;19:1076-7
16. Nijhara R, Balakrishnan K. Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties. Nanomedicine 2006;2:127-36
17. Barenholz Y. Doxil-The first FDAapproved nano-drug: lessons learned. J Control Release 2012;160:117-34
18. Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol 2006;24:1211-18
19. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-82
20. Hrkach J, Von Hoff D, Ali MM, et al. Preclinical development and clinical translation of a PSMA-Targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med 2012;4:128ra39
21. Sahay G, Querbes W, Alabi C, et al. Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat Biotechnol 2013;31:653-8
22. Tsurkan MV, Hauser PV, Zieris A, et al. Growth factor delivery from hydrogel particle aggregates to promote tubular regeneration after acute kidney injury. J Control Release 2013;167:248-55
23. Tenzer S, Docter D, Kuharev J, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 2013;8:772-81
24. Sakurai Y, Hatakeyama H, Sato Y, et al. Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system. Mol Ther 2013;21:1195-203
25. Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2007;2:469-78
26. Alonso MJ. Nanomedicines for overcoming biological barriers. Biomed Pharmacother 2004;58:168-72
27. Chauhan VP, Stylianopoulos T, Martin JD, et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a sizedependent manner. Nat Nanotechnol 2012;7:383-8
28. Hotze EM, Phenrat T, Lowry GV. Nanoparticle aggregation: challenges to understanding transport and reactivity in the environment. J Environ Qual 2010;39:1909-24
29. Lesniak A, Campbell A, Monopoli MP, et al. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 2010;31:9511-18
30. Walkey CD, Olsen JB, Guo H, et al. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 2011;134:2139-47
31. Salvati A, Pitek AS, Monopoli MP, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 2013;8:137-43
32. Ernsting MJ, Murakami M, Roy A, Li S-D. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release 2013;172:782-94
33. Kutscher HL, Chao P, Deshmukh M, et al. Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats. J Control Release 2010;143:31-7
34. Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 2003;55:403-19
35. Noga M, Edinger D, Kläger R, et al. The effect of molar mass and degree of hydroxyethylation on the controlled shielding and deshielding of hydroxyethyl starch-coated polyplexes. Biomaterials 2013;34:2530-8
36. Bader RA, Silvers AL, Zhang N. Polysialic acid-based micelles for encapsulation of hydrophobic drugs. Biomacromolecules 2011;12:314-20
37. Owens III DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93-102
38. Champion JA, Katare YK, Mitragotri S. Particle shape: a new design parameter for micro-And nanoscale drug delivery carriers. J Control Release 2007;121:3-9
39. Daum N, Tscheka C, Neumeyer A, Schneider M. Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012;4:52-65
40. Mathaes R, Winter G, Engert J, Besheer A. Application of different analytical methods for the characterization of non-spherical microand nanoparticles. Int J Pharm 2013;453:620-9
41. Champion JA, Katare YK, Mitragotri S. Making polymeric micro-And nanoparticles of complex shapes. Proc Natl Acad Sci USA 2007;104:11901-4
42. Kersey FR, Merkel TJ, Perry JL, et al. Effect of aspect ratio and deformability on nanoparticle extravasation through nanopores. Langmuir 2012;28:8773-81
43. Morton SW, Herlihy KP, Shopsowitz KE, et al. Scalable manufacture of built-To-order nanomedicine: spray-Assisted layer-by-layer functionalization of PRINT nanoparticles. Adv Mater 2013;25:4707-13
44. Gratton SE, Ropp PA, Pohlhaus PD, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 2008;105:11613-18
45. Xu J, Luft JC, Yi X, et al. RNA replicon delivery via lipid-complexed PRINT protein particles. Mol Pharm 2013;10:3366-74
46. Rolland JP, Maynor BW, Euliss LE, et al. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J Am Chem Soc 2005;127:10096-100
47. Zhang H, Nunes J, Gratton S, et al. Fabrication of multiphasic and regiospecifically functionalized PRINT-particles of controlled size and shape. New J Phys 2009;11:075018
48. Galloway AL, Murphy A, DeSimone JM, et al. Development of a nanoparticlebased influenza vaccine using the PRINT-Technology. Nanomedicine 2013;9:523-31
49. Enlow EM, Luft JC, Napier ME, DeSimone JM. Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings. Nano Lett 2011;11:808-13
50. Petros RA, Ropp PA, DeSimone JM. Reductively labile PRINT particles for the delivery of doxorubicin to HeLa cells. J Am Chem Soc 2008;130:5008-9
51. Chu KS, Schorzman AN, Finniss MC, et al. Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy. Biomaterials 2013;34:8424-9
52. Xu S, Nie Z, Seo M, et al. Generation of monodisperse particles by using microfluidics: control over size, shape, and composition. Angew Chem Int Ed Engl 2005;117:734-8
53. Shang L, Shangguan F, Cheng Y, et al. Microfluidic generation of magnetoresponsive Janus photonic crystal particles. Nanoscale 2013;5:9553-7
54. Hakimi N, Tsai SSH, Cheng C-H, Hwang DK. One-step two-dimensional microfluidics-based synthesis of threedimensional particles. Adv Mater 2014;26:1393-8
55. Dendukuri D, Pregibon DC, Collins J, et al. Continuous-flow lithography for high-Throughput microparticle synthesis. Nat Mater 2006;5:365-9
56. Love JC, Wolfe DB, Jacobs HO, Whitesides GM. Microscope projection photolithography for rapid prototyping of masters with micron-scale features for use in soft lithography. Langmuir 2001;17:6005-12
57. Yin Y, Lu Y, Gates B, Xia Y. Template-Assisted self-Assembly: a practical route to complex aggregates of monodispersed colloids with well-defined sizes, shapes, and structures. J Am Chem Soc 2001;123:8718-29
58. Lee SA, Chung SE, Park W, et al. Three-dimensional fabrication of heterogeneous microstructures using soft membrane deformation and optofluidic maskless lithography. Lab Chip 2009;9:1670-5
59. Chung SE, Park W, Shin S, et al. Guided and fluidic self-Assembly of microstructures using railed microfluidic channels. Nat Mater 2008;7:581-7
60. Kim H, Ge J, Kim J, et al. Structural colour printing using a magnetically tunable and lithographically fixable photonic crystal. Nat Photonics 2009;3:534-40
61. Nisisako T, Torii T. Microfluidic largescale integration on a chip for mass production of monodisperse droplets and particles. Lab Chip 2008;8:287-93
62. Ho CC, Keller A, Odell JA, Ottewill RH. Preparation of monodisperse ellipsoidal polystyrene particles. Colloid Polym Sci 1993;271:469-79
63. Doshi N, Prabhakarpandian B, Rea-Ramsey A, et al. Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. J Control Release 2010;146:196-200
64. Doshi N, Zahr AS, Bhaskar S, et al. Red blood cell-mimicking synthetic biomaterial particles. Proc Natl Acad Sci USA 2009;106:21495-9
65. Yoo J-W, Doshi N, Mitragotri S. Endocytosis and intracellular distribution of PLGA particles in endothelial cells: effect of particle geometry. Macromol Rapid Commun 2010;31:142-8
66. Yin Y, Xia Y. Self-Assembly of monodispersed spherical colloids into complex aggregates with well-defined sizes, shapes, and structures. Adv Mater 2001;13:267-71
67. Yin Y, Xia Y. Self-Assembly of spherical colloids into helical chains with wellcontrolled handedness. J Am Chem Soc 2003;125:2048-9
68. Vanapalli SA, Iacovella CR, Sung KE, et al. Fluidic assembly and packing of microspheres in confined channels. Langmuir 2008;24:3661-70
69. Velev OD, Lenhoff AM, Kaler EW. A class of microstructured particles through colloidal crystallization. Science 2000;287:2240-3
70. Kohler D, Schneider M, Krüger M, et al. Template-Assisted polyelectrolyte encapsulation of nanoparticles into dispersible, hierarchically nanostructured microfibers. Adv Mater 2011;23:1376-9
71. Foss CA Jr, Tierney MJ, Martin CR. Template synthesis of infraredtransparent metal microcylinders: comparison of optical properties with the predictions of effective medium theory. J Phys Chem 1992;96:9001-7
72. Yu Y-Y, Chang S-S, Lee C-L, Wang CC. Gold nanorods: electrochemical synthesis and optical properties. J Phys Chem B 1997;101:6661-4
73. Busbee BD, Obare SO, Murphy CJ. An improved synthesis of high-Aspect-ratio gold nanorods. Adv Mater 2003;15:414-16
74. Huh S, Wiench JW, Yoo J-C, et al. Organic functionalization and morphology control of mesoporous silicas via a co-condensation synthesis method. Chem Mater 2003;15:4247-56
75. Bjeork EM, Seoderlind F, Od-en M. Tuning the shape of mesoporous silica particles by alterations in parameter space: from rods to platelets. Langmuir 2013;29:13551-61
76. Lee BK, Yun YH, Choi JS, et al. Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system. Int J Pharm 2012;427:305-10
77. Raphael AP, Primiero CA, Ansaldo AB, et al. Elongate microparticles for enhanced drug delivery to ex vivo and in vivo pig skin. J Control Release 2013;172:96-104
78. Ajayan PM, Zhou OZ. Applications of carbon nanotubes. In: Carbon nanotubes. Springer, Springer Berlin Heidelberg; 2001. p. 391-425, Chapter 14; ISBN 978-3-540-41086-7
79. Lepeltier E, Bourgaux C, Maksimenko A, et al. Self-Assembly of polyisoprenoyl gemcitabine conjugates: influence of supramolecular organization on their biological activity. Langmuir 2014;30:6348-57
80. Jores K, Mehnert W, Mäder K. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study. Pharm Res 2003;20:1274-83
81. Alemdaroglu FE, Alemdaroglu NC, Langguth P, Herrmann A. Cellular uptake of DNA block copolymer micelles with different shapes. Macromol Rapid Commun 2008;29:326-9
82. Geng Y, Dalhaimer P, Cai S, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2007;2:249-55
83. Martínez MJ, Simon-pujol D, Congregado F, et al. The presence of capsular polysaccharide in mesophilic Aeromonas hydrophila serotypes O:11 and O:34. FEMS Microbiol Lett 1995;128:69-73
84. Doshi N, Mitragotri S. Macrophages recognize size and shape of their targets. PLoS One 2010;5:e10051
85. Champion J, Mitragotri S. Shape induced inhibition of phagocytosis of polymer particles. Pharm Res 2009;26:244-9
86. Mathaes R, Winter G, Besheer A, Engert J. Influence of particle geometry and PEGylation on phagocytosis of particulate carriers. Int J Pharm 2014;465:159-64
87. Qiu Y, Liu Y, Wang L, et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010;31:7606-19
88. Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006;6:662-8
89. Arnida Janát-Amsbury MM, Ray A, et al. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 2011;77:417-23
90. Malugin A, Ghandehari H. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol 2010;30:212-17
91. Agarwal R, Singh V, Jurney P, et al. Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms. Proc Natl Acad Sci USA 2013;110:17247-52
92. Zhang K, Fang H, Chen Z, et al. Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake. Bioconjug Chem 2008;19:1880-7
93. Muro S, Garnacho C, Champion JA, et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-Targeted carriers. Mol Ther 2008;16:1450-8
94. Sharma G, Valenta DT, Altman Y, et al. Polymer particle shape independently influences binding and internalization by macrophages. J Control Release 2010;147:408-12
95. Decuzzi P, Ferrari M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 2006;27:5307-14
96. Decuzzi P, Pasqualini R, Arap W, Ferrari M. Intravascular delivery of particulate systems: does geometry really matter? Pharm Res 2009;26:235-43
97. Barua S, Yoo J-W, Kolhar P, et al. Particle shape enhances specificity of antibody-displaying nanoparticles. Proc Natl Acad Sci USA 2013;110:3270-5
98. Herd H, Daum N, Jones AT, et al. Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano 2013;7:1961-73
99. Lee S-Y, Ferrari M, Decuzzi P. Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology 2009;20:495101
100. Gentile F, Chiappini C, Fine D, et al. The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. J Biomech 2008;41:2312-18
101. Toy R, Hayden E, Shoup C, et al. The effects of particle size, density and shape on margination of nanoparticles in microcirculation. Nanotechnology 2011;22:115101
102. Niidome T, Yamagata M, Okamoto Y, et al. PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 2006;114:343-7
103. Akiyama Y, Mori T, Katayama Y, Niidome T. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release 2009;139:81-4
104. Perry JL, Reuter KG, Kai MP, et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett 2012;12:5304-10
105. Liu Z, Cai W, He L, et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2007;2:47-52
106. Yang K, Wan J, Zhang S, et al. In vivo pharmacokinetics, long-Term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 2010;5:516-22
107. Merkel TJ, Chen K, Jones SW, et al. The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. J Control Release 2012;162:37-44
108. Merkel TJ, Jones SW, Herlihy KP, et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc Natl Acad Sci USA 2011;108:586-91
109. Kolhar P, Anselmo AC, Gupta V, et al. Using shape effects to target antibodycoated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci USA 2013;110:10753-8
110. Yu T, Hubbard D, Ray A, Ghandehari H. In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. J Control Release 2012;163:46-54
111. Decuzzi P, Godin B, Tanaka T, et al. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release 2010;141:320-7
112. Godin B, Chiappini C, Srinivasan S, et al. Discoidal porous silicon particles: fabrication and biodistribution in breast cancer bearing mice. Adv Funct Mater 2012;22:4225-35
113. Niikura K, Matsunaga T, Suzuki T, et al. Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. ACS Nano 2013;7:3926-38